Isn't bauxite the pulse? The rationale for the merger is to generate cash from bauxite then develop the Surat. Sounds feasible (unless the bauxite runs into the Irwins again?)
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
